Platinum ion uptake by dendrimers: an NMR and AFM study

The reaction of generation 2 and generation 4 poly(amidoamine) (PAMAM) dendrimers with K2PtCl2 was studied by several NMR methods. The time dependency of the Pt(II) complexation was followed with 195Pt NMR for both dendrimers and the equilibrium product was further characterized with (1)H NMR, and indirectly detected 13C NMR, in the case of the generation 2 dendrimer. After 2 days, a black precipitate of Pt(0) was observed, half the original 195Pt signal was lost, and approximately 20% of the initial Pt(II) was coordinated to the tertiary and secondary nitrogens of the generation 2 dendrimer. The uptake of Pt(II) by the generation 4 dendrimer was much slower, consistent with the steric crowding of the surface groups on the generation 4 dendrimer compared to the more open generation 2. After 10 days, 80% of the Pt(II) was deep within the generation 4 dendrimer; the remaining 20% was unreacted or bound near the surface nitrogens of a single dendrimer. The location and time course of the platinum ion uptake by the dendrimers provides valuable insight into the formation of Pt(0) nanoparticles made in the presence of dendrimers as stabilizers, visualized by atomic force microscopy.     

EXAFS characterization of dendrimer-Pt nanocomposites used for the preparation of Pt/gamma-Al2O3 catalysts

Pt/gamma-Al2O3 catalysts were prepared using hydroxyl-terminated generation four (G4OH) PAMAM dendrimers as the templating agents and the various steps of the preparation process were monitored by extended X-ray absorption fine structure (EXAFS) spectroscopy. The EXAFS results indicate that, upon hydrolysis, chlorine ligands in the H(2)PtCl(6) and K(2)PtCl(4) precursors were partially replaced by aquo ligands to form [PtCl3(H2O)3]+ and [PtCl2(H2O)2] species, respectively. The results further suggest that, after interaction of such species with the dendrimer molecules, chlorine ligands from the first coordination shell of Pt were replaced by nitrogen atoms from the dendrimer interior, indicating that complexation took place. This process was accompanied by a substantial transfer of electron density from the dendrimer to platinum, indicating that the dendrimer plays the role of a ligand. Following treatment of the H(2)PtCl(6)/G4OH and K(2)PtCl(4)/G4OH complexes with NaBH4, no substantial changes were observed in the electronic or coordination environment of platinum, indicating that metal nanoparticles were not formed during this step under our experimental conditions. However, when the reduction treatment was performed with H2, the formation of extremely small platinum clusters, incorporating no more than four Pt atoms was observed. The nuclearity of these clusters depends on the length of the hydrogen treatment. These Pt species remained strongly bonded to the dendrimer. Formation of larger platinum nanoparticles, with an average diameter of approximately 10 A, was finally observed after the deposition and drying of the H(2)PtCl(6)/G4OH nanocomposites on a gamma-Al(2)O(3) surface, suggesting that the formation of such nanoparticles may be related to the collapse of the dendrimer structure. The platinum nanoparticles formed appear to have high mobility because subsequent thermal treatment in O2/H2, used to remove the dendrimer component, led to further sintering.     

Preparation of PAMAM- and PPI-metal (silver, platinum, and palladium) nanocomposites and their catalytic activities for reduction of 4-nitrophenol

Dendrimer-metal (silver, platinum, and palladium) nanocomposites are prepared in aqueous solutions containing poly(amidoamine) (PAMAM) dendrimers with surface amino groups (generations 3, 4, and 5) or poly(propyleneimine) (PPI) dendrimers with surface amino groups (generations 2, 3, and 4). The particle sizes of the metal nanoparticles obtained are almost independent of the generation as well as the concentration of the dendrimer for both the PAMAM and the PPI dendrimers; the average sizes of silver, platinum, and palladium nanoparticles are 5.6-7.5, 1.2-1.6, and 1.6-2.0 nm, respectively. It is suggested that the dendrimer-metal nanocomposites are formed by adsorbing the dendrimers on the metal nanoparticles. Studies of the reduction reaction of 4-nitrophenol by these nanocomposites show that the rate constants are very similar between PAMAM and PPI dendrimer-silver nanocomposites, whereas the rate constants for the PPI dendrimer-platinum and -palladium nanocomposites are greater than those for the corresponding PAMAM dendrimer nanocomposites. In addition, it is found that the rate constants for the reduction of 4-nitrophenol involving all the dendrimer-metal nanocomposites decrease with an increase in the dendrimer concentrations, and the catalytic activity of dendrimer-palladium nanocomposites is highest.     

New Cisplatin Analogues—On the Way to Better Antitumor Agents

The clinical success of cisplatin (cis -diamminedichloroplatinum(II )) in antitumor chemotherapy has encouraged an all-out search for analogues with lower toxicity, improved therapeutic index and increased activity. Literally thousands of analogues, obtained by replacement of the ammine- and chloro-ligands by other amines and anionic ligands, respectively, have been systematically screened for activity in experimental tumor models. Some of these analogues have been selected for clinical evaluation, but only very few of them appear to be promising antitumor agents. More recently, cisplatin analogues have been designed and synthesized on the basis of, inter alia, the following considerations: 1) platinum complexes with carrier molecules as ligands should prove useful for achieving increasing drug concentration in tumor tissues; 2) platinum complexes with chemotherapeutic agents as ligands could afford polyfunctional drugs with synergistic action; 3) complexes containing more than one platinum atom might be more effective than complexes containing only one platinum atom; 4) platinum complexes could be used as sensitizers in radiation therapy. In this paper, we shall give a brief account of the “traditional” analogues, and then critically discuss what we believe could be the new trends in the design of cisplatin analogues.     

Use of Half-Generation PAMAM Dendrimers (G0.5–G3.5) with Carboxylate End-Groups to Improve the DACHPtCl2 and 5-FU Efficacy as Anticancer Drugs

The DACHPtCl₂ compound (trans-(R,R)-1,2-diaminocyclohexanedichloroplatinum(II)) is a potent anticancer drug with a broad spectrum of activity and is less toxic than oxaliplatin (trans-l-diaminocyclohexane oxalate platinum II), with which it shares the active metal fragment DACHPt. Nevertheless, due to poor water solubility, its use as a chemotherapeutic drug is limited. Here, DACHPtCl₂ was conjugated, in a bidentate form, with half-generation PAMAM dendrimers (G0.5–G3.5) with carboxylate end-groups, and the resulting conjugates were evaluated against various types of cancer cell lines. In this way, we aimed at increasing the solubility and availability at the target site of DACHPt while potentially reducing the adverse side effects. DNA binding assays showed a hyperchromic effect compatible with DNA helix’s disruption upon the interaction of the metallodendrimers and/or the released active metallic fragments with DNA. Furthermore, the prepared DACHPt metallodendrimers presented cytotoxicity in a wide set of cancer cell lines used (the relative potency regarding oxaliplatin was in general high) and were not hemotoxic. Importantly, their selectivity for A2780 and CACO-2 cancer cells with respect to non-cancer cells was particularly high. Subsequently, the anticancer drug 5-FU was loaded in a selected metallodendrimer (the G2.5COO(DACHPt)₁₆) to investigate a possible synergistic effect between the two drugs carried by the same dendrimer scaffold and tested for cytotoxicity in A2780cisR and CACO-2 cancer cell lines. This combination resulted in IC₅₀ values much lower than the IC₅₀ for 5-FU but higher than those found for the metallodendrimers without 5-FU. It seems, thus, that the metallic fragment-induced cytotoxicity dominates over the cytotoxicity of 5-FU in the set of considered cell lines.     

Thermal and spectroscopic investigation of new binuclear Pt(II) complexes with carboxylic acids

The thermal decomposition of the binuclear Pt(II) complexes with acetate, propionate, valerate and izovalerate ligands were studied by TG and DTA techniques. The Pt(II) complex with acetic acid (PtAA) was stable up to 343.15 K, Pt(II) complex with propionic acid (PtPrA) was stable up to 323.15 K, Pt(II) complex with valeric acid (PtVA) was stable up to T=313.15 K and Pt(II) complex with isovaleric acid (PtIvA) was stable up to 408.15 K. The PtAA complex was investigated again after a year by thermogravimetric analysis. After the thermal decomposition of the Pt(II) complexes with carboxylic acids, only in the PtVA complex and PtAA complex (investigated after a year) the final residue contains only platinum, while in the rest complexes the solid residue was a mixture of platinum and platinum carbides (PtC₂, Pt₂C₃).     

Synthesis and Opto‐electronic Properties of a Red‐Emitting Heteroleptic Platinum Complex Using Pyrazol‐based Diketone Derivative as Ancillary Ligand

A red‐emitting heteroleptic cyclometalated platinum(II) complex containing an ancillary ligand of pyrazol‐based diketone derivative was synthesized. Its optophysical and electroluminescent properties were studied. Compared to the reported (piq)Pt(acac) complex, this platinum(II) complex exhibited a blue‐shifted UV absorption band at 300–450 nm, a low LUMO energy level and improved electroluminescent property. Using this platinum(II) complex as a single doping emitter and a blend of ploy(9,9‐dioctylfluorene) and 2‐tert‐butylphenyl‐5‐phenyl‐1,3,4‐oxadiazole as a host matrix, the fabricated polymer light‐emitting devices displayed saturated red emission with a peak at 648 nm and a shoulder at 601 nm. Furthermore, the emission quenching of the platinum(II) complex was significantly suppressed in these devices at high current density due to an introduction of the non‐planar pyrazol group into the ancillary ligand.     

Thermal degradation of platinum(IV) precursors to antitumor drugs

Organoplatinum antitumor agents are very effective, broad-spectrum drugs used for the treatment of a variety of cancerous conditions. The two most prominent of these, Cisplatin [cis-diamminodichloroplatinum(II)] and Carboplatin [diammino(1,1-cyclobutanedicarboxylato)platinum(II)], are large scale commercial successes. The third, Oxaliplatin [((trans-1,2-diamminocyclohexane)oxalato)platinum(II)], is now commercially available. The administration of all these drugs is accompanied by severe side effects. For Cisplatin, the most debilitating of these is kidney damage and extreme nausea. Several approaches to generate drug-release formulations that might mitigate toxic side effects have been explored. Now, platinum(IV) compounds which are more inert than platinum(II) compounds, and consequently less toxic, but which may be reduced to platinum(II) species within the cell are being evaluated for effectiveness in the treatment of cancer. The thermal stability of several precursors to compounds of this kind has been examined by thermogravimetry. In general, these materials lose ligands sequentially to generate a residue of platinum. This behavior may be generally useful for the characterization of such materials.     

Synthesis and mesomorphic properties of some platinum(II) and oxovanadium(IV) complexes

The synthesis and mesomorphic properties of a homologous series of N-(2-hydroxy-4-n-alkoxybenzylidene)-4'-n-decylphenylanilines and their platinum(II) and oxovanadium(IV) complexes are reported. All the ligands and their metal chelates exhibit enantiotropic mesophases, predominantly smectic A and smectic C phases. The transition temperatures and enthalpies have been determined for most of the compounds. The platinum(II) complexes have higher melting points and mesophase thermal stabilities. However, the oxovanadium(IV) complexes have a wider thermal range for the mesophase. Both platinum(II) and oxovanadium(IV) complexes containing only a chain on the biphenyl moiety exhibit a nematic phase.     

FORCE FIELD CALCULATIONS OF ANTITUMOR PLATINUM(II) COMPLEX SYSTEMS

Abstract

Strain-energy minimization calculations of adducts of platinum(II) complexes containing 1,2-diaminocyclohexane (DACH) with the sequence d(pCpGpAp)·d(pGpCpTp) of a synthetic B-DNA were carried out by using a modification of the MM2 program. (C, G, A, T, and p denote cytidine, guanosine, adenosine, thymidine, and phosphate, respectively). In result, the more antitumor-active trans-DACH complex adducts are about 37 kJ/mol more stable than the cis complex in total energy.

Platinum-complex adducts of 2-(aminomethyl)cyclohexylamine abbreviated as AMCHA were also estimated. In calculations, the trans-AMCHA-complex adducts are about 6 to 14 kJ/mol more stable than the cis ones. The differences are less than between the DACH complexes. In addition, this relaxation of strain occurred in the six-membered ring.     

Highly Stable Water‐Soluble Platinum Nanoparticles Stabilized by Hydrophilic N‐Heterocyclic Carbenes

Controlling the synthesis of stable metal nanoparticles in water is a current challenge in nanochemistry. The strategy presented herein uses sulfonated N‐heterocyclic carbene (NHC) ligands to stabilize platinum nanoparticles (PtNPs) in water, under air, for an indefinite time period. The particles were prepared by thermal decomposition of a preformed molecular Pt complex containing the NHC ligand and were then purified by dialysis and characterized by TEM, high‐resolution TEM, and spectroscopic techniques. Solid‐state NMR studies showed coordination of the carbene ligands to the nanoparticle surface and allowed the determination of a ¹³C–¹⁹⁵Pt coupling constant for the first time in a nanosystem (940 Hz). Additionally, in one case a novel structure was formed in which platinum(II) NHC complexes form a second coordination sphere around the nanoparticle.     

非经典铂类抗肿瘤药物研究

本文综述了非经典铂类抗肿瘤药物的发展概况,介绍了具有口服活性的铂(Ⅳ)配合物,具有空间位阻的铂(Ⅱ)配合物,反式铂(Ⅱ、Ⅳ)配合物,多核铂(Ⅱ)配合物和含有铂-硫键的铂(Ⅱ)配合物,并总结了这几类新型铂配合物的抗肿瘤机理,克服顺铂的耐药性机理及其临床进展。     

The thermal degradation characteristics of selected organoplatinum antitumor agents

The thermal decomposition characteristics of representatives of three classes of organoplatinum compounds have been examined by thermogravimetry. Substituted salicylato(1,2-diaminocyclohexane)platinum(II) compounds undergo thermal decomposition by sequential loss of first the salicylato ligand and then the amine ligand to afford a residue corresponding to the platinum content of the compound. The thermal decomposition of N-arylsalicylaldimino(1,2-diaminocyclohexane)platinum(II) nitrate is more complex, but is also characterized by two major weight losses. Thermal decomposition ofbis-(2-thiophenecarboxylato)platinum(II) is characterized by ligand fragmentation to generate a residual mass corresponding to the platinum content of the compound.     

钯(Ⅱ)类抗肿瘤药物研究进展

20世纪60年代,美国密执安州立大学Rosenberg发现了顺铂具有抗癌活性,开辟了金属类抗肿瘤药物研究的新领域.经过40余年的研究,已相继成功开发了卡铂、奈达铂、奥沙利铂、舒铂、洛铂和双环铂等铂类抗肿瘤药物.虽然对于铂类抗肿瘤药物研究取得了一定的成绩,但在临床使用过程中也存在一些问题,如其毒副作用和抗药性,限制了其在临床上的进一步广泛应用.为了解决这些问题,科研工作者开始寻找新的金属类抗肿瘤药物以弥补现有铂类抗肿瘤药物的不足.在金属元素中,唯有钯(II)与铂(II)配合物具有相似或相同的结构特征,进而表现出相近或相似的化学性质.因此,继铂类抗肿瘤配合物后,钯(II)配合物作为潜在抗肿瘤药物成为一个诱人的领域.本文综述了近年来钯(II)类抗肿瘤药物的研究进展,并探讨了其构效关系,这对于指导新型钯(II)类抗肿瘤药物的合成具有重要的参考价值.     

Poly(propylene imine) dendrimer complexes of Cu(II), Zn(II), and Co(III) as catalysts of hydrolysis of p-nitrophenyl diphenyl phosphate

Poly(propylene imine) dendrimers having 8, 32, and 64 primary amine end groups form diamino Cu(II), diamino Zn(II), and tetramino Co(III) complexes that are identified spectrophotometrically and titrimetrically. The dendrimer–metal ion complexes catalyze the hydrolysis of p-nitrophenyl diphenyl phosphate in zwitterionic buffer solutions at pH ≤ 8.1 with relative activities Cu(II) > Zn(II) > Co(III). The rates of hydrolysis are faster with sodium perchlorate than with sodium chloride to control ionic strength. In sodium perchlorate solutions with Cu(II) the rates increase with increasing size of the dendrimer. In sodium chloride solutions with Cu(II) the rates decrease with increasing size of the dendrimer. Rate constants in buffered sodium chloride solutions of dendrimers and 1.0mM Cu(II) are 1.3–6.3 times faster than in the absence of Cu(II). The fastest hydrolyses occurred at a dendrimer primary amine to Cu(II) ratio NH₂/Cu ≤ 2. At NH₂/Cu = 4 and with the 1,4,7,10-tetraazacyclodecane complex of Cu(II) hydrolysis rates were much slower. © 1999 John Wiley & Sons, Inc. J Polym Sci A: Polym Chem 37: 2727–2736, 1999     

Design of Enzymatically Cleavable Prodrugs of a Potent Platinum‐Containing Anticancer Agent

Using a versatile synthetic approach, a new class of potential ester prodrugs of highly potent, but systemically too toxic, platinum–acridine anticancer agents was generated. The new hybrids contain a hydroxyl group, which has been masked with a cleavable lipophilic acyl moiety. Both butanoic (butyric) and bulkier 2‐propanepentanoic (valproic) esters were introduced. The goals of this design were to improve the drug‐like properties (e.g., logD) and to reduce the systemic toxicity of the pharmacophore. Two distinct pathways by which the target compounds undergo effective ester hydrolysis, the proposed activating step, have been confirmed: platinum‐assisted, self‐immolative ester cleavage in a low‐chloride environment (LC‐ESMS, NMR spectroscopy) and enzymatic cleavage by human carboxylesterase‐2 (hCES‐2) (LC‐ESMS). The valproic acid ester derivatives are the first example of a metal‐containing agent cleavable by the prodrug‐converting enzyme. They show excellent chemical stability and reduced systemic toxicity. Preliminary results from screening in lung adenocarcinoma cell lines (A549, NCI‐H1435) suggest that the mechanism of the valproic esters may involve intracellular deesterification.     

Distinctive features of supported catalysts prepared from platinum carbonyl clusters

The formation of Pt/γ-Al₂O₃ and Pt/C catalysts from platinum carbonyl clusters H₂[Pt₃(CO)₆]_n (n = 2, 5) is studied. The strength of interaction between clusters (strong Lewis bases) and the support and the state of platinum in catalysts are governed by the acceptor strength of the support. The formation of a stable platinum compound with a surface of γ-Al₂O₃ (strong Lewis acid) is shown for a Pt/γ-Al₂O₃ catalyst by the method of radial distribution functions. In a Pt/C catalyst containing the same amount of Pt supported on a carbon material known to be a weaker acceptor, metallic platinum is formed along with surface-bonded platinum. Proceeding from the existence of the active phase of catalysts in the form of a surface platinum complex and platinum crystallites, the properties of catalysts are discussed in the complete oxidation of methane and the dehydrogenation of cyclohexane, as well as the high dispersity of platinum and its thermal stability     

BisN(chlorophenyl)dithiocarbamato complexes of cobalt(II), nickel(II), palladium(II) and platinum(II)

Summary Cobalt(II), nickel(II), palladium(II) and platinum(II) complexes witho-(OCD),m-(MCD) andp-chlorophenyldithiocarbamate (PCD) ligands have been synthesised and characterised by chemical analyses, molecular weight determinations, conductance measurements, electronic and i.r. spectral studies. The thermal behaviour of the complexes has been studied by t.g. and d.t.a. techniques in a static air atmosphere and heats of reaction of different decomposition steps have been calculated from the d.t.a. curves. The thermal decomposition products of the complexes were identified by elemental analyses and i.r. spectra.     

EPR characterization of gadolinium(III)-containing-PAMAM-dendrimers in the absence and in the presence of paramagnetic probes

Gd(III)-containing dendrimers are promising contrast agents for magnetic resonance imaging (MRI). An important issue in the effectiveness and toxicity of a Gd(III) based MRI contrast agent is knowledge of the relative locations and concentrations of Gd(III) in dendrimer drug delivery hosts. In order to provide experimental information on this issue, we have investigated the electron paramagnetic resonance (EPR) of a stable Gd(III) complex with diethylenetriaminepentaacetic acid (DTPA) in various polyammidoamine (PAMAM) dendrimers as a function of dendrimer generation (G2, G4, and G6), dendrimer core (ethylenediamine = EDA, and cystamine = cys), and dendrimer surface functionality (NH(2), 5-oxo-3-pyrrolidinecarboxylic acid methyl ester = pyr, and tris(hydroxymethyl) methylamine = tris). The dendrimer systems were investigated in the presence and absence of paramagnetic probes, that is, Cu(II) and nitroxide radicals (4-(trimethylammonium and dodecyl-dimethylammonium) 2,2,6,6-tetramethylpiperidine 1-oxyl bromide = CAT1 and CAT12, respectively). The analysis of the EPR spectra revealed anisotropic locations of Gd-DTPA inside the dendrimer. Computer analysis of the EPR spectra of the probes identified the interactions of the Gd-dendrimers with ions and organic molecules. The interaction between the probes and the dendrimer internal and external surface depends on the type of core, the composition of the external surface and the generation of the dendrimer. The negatively charged Gd-DTPA complex attracts the positively charged species and this provokes spin-spin interactions between Gd and the probes, which increases with a decrease in generation, mainly from G6 to G4, and with an increase in both the Gd-dendrimer concentration and the probe concentration. The cys core increases the internal volume and decreases the packing of the branches.     

Synthesis and characterization of a ligand‐substituted poly(amidoamine) dendrimer with external terpyridine units and its iron(II) complexes

The ligand‐substituted poly(amido amine) dendrimer 2 containing terpyridine ligands located exclusively at the peripheries of the dendrimer and its iron‐containing dendrimer 3 have been synthesized using modification reactions. Cyclic voltammetric studies indicate that the external iron centers on the outer surface of the dendrimer are electrochemically equivalent. The treatment of 2 with Fe²⁺ ions leads to a dendrimer assembly due to the formation of iron complexes among the ligand‐substituted dendrimers.